EcoDrugPlus

Complement C5

Ensembl ID : ENSCHYG00000006574
Gene Symbol: C5
1 Cross references
212 Possible Orthologues:

Complement Factor D

Ensembl ID : ENSCHYG00000007923
Gene Symbol: CFD
1 Cross references
134 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSCHYG00000003519
Gene Symbol: CRHR1
1 Cross references
208 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSCHYG00000000255
Gene Symbol: CCND1
1 Cross references
274 Possible Orthologues:

Cyclin Dependent Kinase 5

Ensembl ID : ENSCHYG00000025073
Gene Symbol: CDK5
1 Cross references
169 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSCHYG00000010888
Gene Symbol: CDK6
1 Cross references
201 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSCHYG00000018317
Gene Symbol: CDK9
1 Cross references
207 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSCHYG00000009807
Gene Symbol: CYSLTR1
1 Cross references
181 Possible Orthologues:

Cytochrome P450 Family 26 Subfamily A Member 1

Ensembl ID : ENSCHYG00000007274
Gene Symbol: CYP26A1
1 Cross references
208 Possible Orthologues:

Cytochrome P450 Family 46 Subfamily A Member 1

Ensembl ID : ENSCHYG00000010065
Gene Symbol: CYP46A1
1 Cross references
260 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1

Ensembl ID : ENSCHYG00000008972
Gene Symbol: DGAT1
1 Cross references
262 Possible Orthologues:

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSCHYG00000022843
Gene Symbol: DHODH
1 Cross references
173 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).